Upper eyelid Merkel cell carcinoma treated with neoadjuvant chemotherapy and surgical excision
- Author:
Vito TOTO
1
;
Alfredo COLAPIETRA
;
Mario ALESSANDRI-BONETTI
;
Bruno VINCENZI
;
Valeria DEVIRGILIIS
;
Vincenzo PANASITI
;
Paolo PERSICHETTI
Author Information
- Publication Type:Case Report
- Keywords: Carcinoma; Chalazion; Eyelid neoplasm; Merkel cell; Neoadjuvant therapy; Skin neoplasm
- MeSH: Aged; Biopsy; Carcinoma, Merkel Cell; Chalazion; Drug Therapy; Eyelid Neoplasms; Eyelids; Female; Follow-Up Studies; Humans; Mortality; Muscles; Neoadjuvant Therapy; Recurrence; Skin Neoplasms
- From:Archives of Craniofacial Surgery 2019;20(2):121-125
- CountryRepublic of Korea
- Language:English
- Abstract: Merkel cell carcinoma is a rare cutaneous carcinoma, featured by an aggressive clinical course and a mortality rate of 28% at 2 years. A 71-year-old female was affected by a 4.1-cm-wide locally advanced Merkel cell carcinoma of the upper eyelid, previously misdiagnosed as chalazion, with involvement of the extraocular muscles. Although the tumor showed a macroscopic spontaneous regression in size after the incisional biopsy, the mass was treated with neoadjuvant chemotherapy and surgical excision. Good functional and aesthetic result with preservation of the eyeball and absence of tumor recurrence were achieved at 3-year follow-up. In our experience, the combination of the inflammatory cascade due to the incisional biopsy and neoadjuvant chemotherapy led to the regression of a locally advanced large Merkel cell carcinoma of the eyelid.
